Advertisement

Topics

Actinium Pharmaceuticals, Inc. Company Profile

11:16 EST 19th December 2018 | BioPortfolio

Actinium Pharmaceuticals welcomes you to our website to learn about our important novel
technology for the treatment of cancer.
As part of a worldwide race for a cure for cancer,
Actinium Pharmaceuticals Inc. is developing a safe
and highly effective therapy for cancer and other life
threatening cellular diseases through Alpha Particle
Immunotherapy (APIT). APIT is a groundbreaking
technology in the treatment of cancer

Location

25B Hanover Road
Florham Park
New Jersey
07932
United States of America

Contact

Phone: 973.377.0713
Fax: 973.377.0610
Email: contact@actiniumpharmaceuticals.com


News Articles [308 Associated News Articles listed on BioPortfolio]

Actinium Pharmaceuticals Inc (ATNM-US): Improving -2-

DJ Actinium Pharmaceuticals Inc (ATNM-US): Improving access to CAR-T Dow Jones received a payment from EQS/DGAP to publish this press release. goetzpartners securities Limited Actinium Pharmaceuti...

Actinium Pharmaceuticals Announces Treatment of First Patient in Novel Combination Trial of Actimab-A Plus CLAG-M

- Trial supports Actinium’s strategic expansion of its CD33 program into novel combinations that can lead to increased use of bone marrow transplants and expand the addressable patient population f...

Actinium Pharmaceuticals Announces Dosing of 38th Patient and 25 Percent Enrollment in Iomab-B Pivotal SIERRA Trial

Iomab-B remains the only targeted conditioning treatment in clinical trials with the potential to increase access to and improve outcomes of bone marrow transplant              NEW YORK, Jun...

Actinium Pharmaceuticals (ATNM) Updates On Actimab-A MRD (Clinical trial for Minimal Residual Disease in Postremission AML Patients) - Slideshow

Telix and Nihon Medi-Physics to Collaborate on Actinium Renal Cancer Therapeutics

MELBOURNE, Australia, KYOTO, Japan and TOKYO, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company ...

Actinium Provides Update from Society of Nuclear Medicine and Molecular Imaging Annual Meeting

Two Nuclear Medicine focused advisory boards have been formed to provide expertise and strategic guidance to Actinium  Meeting with Iomab-B and Actimab investigators to be held to provide trial u...

Actinium Announces New Clinical Trial to Study Effect of Actimab-A on Minimal Residual Disease in Postremission AML Patients

Minimal Residual Disease is increasingly recognized as a primary driver of high AML relapse rate highlighting need for improved consolidation therapies Webcast to be held on July 10, 2018 at 8:00 AM...

$ATNM CD33 Program to Focus on Actimab-MDS Pivotal Trial Enabling Study for Targeted Conditioning and Novel Combo Trials with Actimab-A and Venetoclax https://www.prnewswire.com/news-releases/actinium-pharmaceuticals-cd33-program-to-focus-on-actimab-mds-p

$ATNM CD33 Program to Focus on Actimab-MDS Pivotal Trial Enabling Study for Targeted Conditioning and Novel Combo Trials with Actimab-A and Venetoclax https://www.prnewswire.com/news-releases/actini...

Drugs and Medications [270 Associated Drugs and Medications listed on BioPortfolio]

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash

Bacitracin [Qualitest Pharmaceuticals]

Bacitracin Ointment, USP

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash Purified Water, 98.3% Ophthalmic Solution Eyewash

Antacid [Major Pharmaceuticals]

Major Pharmaceuticals Antacid Tablets Drug Facts

Eyewash station additive concentrate [Niagara Pharmaceuticals Inc.]

EYEWASH STATION ADDITIVE CONCENTRATE

PubMed Articles [131 Associated PubMed Articles listed on BioPortfolio]

Actinium-225 for Targeted α Therapy: Coordination Chemistry and Current Chelation Approaches.

The α-emitting radionuclide actinium-225 possesses nuclear properties that are highly promising for use in targeted α therapy (TAT), a therapeutic strategy that employs α particle emissions to dest...

Selective separation of radium and actinium from bulk thorium target material on strong acid cation exchange resin from sulfate media.

This work presents a complete scheme for the selective separation of actinium and radium isotopes from bulk Th target material, in a process that may be applied in a separation scheme for the producti...

The Performance of two silica based ion exchange resins in the separation of Bi from its parent solution of Ac.

The performance of two inorganic ion exchange resins, Isolute SCX and Isolute SCX-2, were compared to the performance of the organic resin AG-50X8 in the separation of the radionuclide bismuth-213 fro...

Swimming activity in zebrafish larvae exposed to veterinary antiparasitic pharmaceuticals.

Veterinary antiparasitic pharmaceuticals have been detected in surface waters and several of these pharmaceuticals act on the nervous system on the target organisms implying that neurological effects ...

Chiral pharmaceuticals: Environment sources, potential human health impacts, remediation technologies and future perspective.

Chiral pharmaceuticals (CPs), including non-steroid anti-inflammatory drugs (NSAIDs), β-blockers and some herbicide and pesticides, are widely used in aquaculture, clinical treatment and many other f...

Clinical Trials [230 Associated Clinical Trials listed on BioPortfolio]

Targeted Atomic Nano-Generators (Actinium-225-Labeled Humanized Anti-CD33 Monoclonal Antibody HuM195) in Patients With Advanced Myeloid Malignancies

The purpose of this study is to find a safe dose of actinium-225 when it is labeled to HuM195. This will be done with a "phase I trial," in which a preset schedule of doses gets more power...

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Companies [1343 Associated Companies listed on BioPortfolio]

Actinium Pharmaceuticals, Inc.

Actinium Pharmaceuticals welcomes you to our website to learn about our important novel technology for the treatment of cancer. As part of a worldwide race for a cure for cancer, Actinium Pharmaceutic...

Maelor Pharmaceuticals Ltd.

Maelor is a publicly listed (AIM:MLR) specialist critical care pharmaceuticals and devices company. The Company has developed an expertise in bringing both pharmaceuticals and devices to the market as...

Excaliard Pharmaceuticals, Inc.

Excaliard Pharmaceuticals, Inc., is a venture capital-funded biotechnology company founded in 2007 focused on the development and commercialization of novel and innovative drugs for the amelioration o...

Serenity Pharmaceuticals

Founded in 2007 and located in Milford, Pennsylvania, Serenity Pharmaceuticals is focused on developing products that address urinary conditions that impact the health and well-be...

Avanir Pharmaceuticals

AVANIR Pharmaceuticals, formerly LIDAK Pharmaceuticals, is a development stage company organized to discover, develop, and market novel therapeutic products to treat human diseases.

More Information about "Actinium Pharmaceuticals, Inc." on BioPortfolio

We have published hundreds of Actinium Pharmaceuticals, Inc. news stories on BioPortfolio along with dozens of Actinium Pharmaceuticals, Inc. Clinical Trials and PubMed Articles about Actinium Pharmaceuticals, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Actinium Pharmaceuticals, Inc. Companies in our database. You can also find out about relevant Actinium Pharmaceuticals, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record